Israel’s Oramed will shortly commence clinical trials of its Oravax vaccine – the world’s first oral Covid-19 vaccine (see here previously). Phase 1/2 trials will take place at Tel Aviv’s Sourasky (Ichilov) Medical Center with Phase 3 in countries desperate … Continue reading →

Israel’s Oramed (reported here previously) has launched Oravax – a joint venture with India’s Premas Biotech to develop a Covid-19 vaccine. The vaccine is administered orally (not injected) and targets 3 virus proteins, so should counter any mutations. Human trials … Continue reading →